TransMedics Group Inc (TMDX) — Capital Reinvestment Ratio
Latest as of March 2026:
1.49x
TransMedics Group Inc (TMDX) has a Capital Reinvestment Ratio of 1.49x as of March 2026, meaning it reinvests 1% of its operating cash flow ($24.53 Million) in capital expenditures ($36.66 Million). See free cash flow generation of TransMedics Group Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.49x
Capex / Operating Cash Flow
Operating Cash Flow
$24.53 Million
USD
Capital Expenditures
$36.66 Million
USD
Data as of
Mar 2026
Most recent filing
TransMedics Group Inc Capital Reinvestment Ratio (2024–2025)
This chart tracks TransMedics Group Inc's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for TransMedics Group Inc (2024–2025)
Year-by-year Capital Reinvestment Ratio for TransMedics Group Inc from 2024 to 2025. For live market cap and broader valuation context, see market value of TransMedics Group Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.31x | $192.84 Million | $59.25 Million | ▼ -88.4% |
| 2024 | 2.66x | $48.80 Million | $129.74 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow